Filing Details

Accession Number:
0001181431-12-016844
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-13 16:26:11
Reporting Period:
2012-03-09
Filing Date:
2012-03-13
Accepted Time:
2012-03-13 16:26:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1400431 Patheon Inc PTI Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1226288 C James Mullen 4721 Emperor Blvd
Suite 200
Durham NC 27703
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Restricted Voting Shares Acquisiton 2012-03-09 15,300 $1.75 999,085 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 12, 2012.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.70 to $1.77, inclusive. The reporting person undertakes to provide to Patheon Inc., any security holder of Patheon Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2). The amounts reported in column 4 and this footnote (2) were converted from Canadian dollars into U.S. dollars based on the March 9, 2012 closing exchange rate of 0.9901 Canadian dollars per U.S. dollar as quoted by Reuters.